Holdings Channel
Size ($ in 1000's)
At 12/31/2023: $585,470
At 09/30/2023: $549,038

Combined Holding Report Includes:
GREAT POINT PARTNERS LLC
JAY JEFFREY R
Yehudai Ortav

Great Point Partners LLC holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Great Point Partners LLC 13F filings. Link to 13F filings: SEC filings

Great Point Partners LLC Top Holdings
As of  12/31/2023, below is a summary of the Great Point Partners LLC top holdings by largest position size, as per the latest 13f filing made by Great Point Partners LLC. In the Great Point Partners LLC-top-holdings-table below, each of the top holdings by name is presented in the first column, followed by the amount of shares held by Great Point Partners LLC in that top holding, then the share count change between reporting periods, and finally the Great Point Partners LLC top holding position size for that row.

   EntityAmountChange
 09/30/2023 to 12/31/2023
Position Size
($ in 1000's)
ALPINE IMMUNE SCIENCES INC 3,703,433 +624,800 $70,587
     ALPN3,703,433+624,800$70,587
CYTOKINETICS INC 500,000 -100,000 $41,745
     CYTK500,000-100,000$41,745
UROGEN PHARMA LTD 2,620,545 UNCH $39,308
     URGN2,620,545UNCH$39,308
PLIANT THERAPEUTICS INC 1,823,184 +68,000 $33,018
     PLRX1,823,184+68,000$33,018
ULTRAGENYX PHARMACEUTICAL IN 648,000 -79,426 $30,987
     RARE648,000-79,426$30,987
XENON PHARMACEUTICALS INC 600,000 +99,999 $27,636
     XENE600,000+99,999$27,636
RAPT THERAPEUTICS INC 1,099,753 -358,317 $27,329
     RAPT1,099,753-358,317$27,329
ALKERMES PLC 875,044 UNCH $24,274
     ALKS875,044UNCH$24,274
AEROVATE THERAPEUTICS INC 1,037,690 -53,543 $23,483
     AVTE1,037,690-53,543$23,483
VAXCYTE INC 360,000 -171,211 $22,608
     PCVX360,000-171,211$22,608
EVOLUS INC 2,000,000 -186,934 $21,060
     EOLS2,000,000-186,934$21,060
ANAPTYSBIO INC 976,981 +82,648 $20,927
     ANAB976,981+82,648$20,927
IMMUNOCORE HLDGS PLC 293,000 +2,083 $20,018
     IMCR293,000+2,083$20,018
NEUROGENE INC 994,229 +994,229 $19,268
     NGNE994,229+994,229$19,268
AMICUS THERAPEUTICS INC 1,280,500 +423,500 $18,170
     FOLD1,280,500+423,500$18,170
TOURMALINE BIO INC 672,885 +672,885 $17,616
     TRML672,885+672,885$17,616
ABIVAX SA 1,550,000 +1,550,000 $16,585
     ABVX1,550,000+1,550,000$16,585
ZURA BIO LTD 3,295,000 UNCH $15,388
     ZURA3,295,000UNCH$15,388
OPTINOSE INC 8,839,939 UNCH $11,404
     OPTN8,839,939UNCH$11,404
APOGEE THERAPEUTICS INC 400,000 UNCH $11,176
     APGE400,000UNCH$11,176
ARVINAS INC 234,082 +234,082 $9,635
     ARVN234,082+234,082$9,635
KARUNA THERAPEUTICS INC 30,250 -30,250 $9,574
     KRTX30,250-30,250$9,574
VISTAGEN THERAPEUTICS INC 1,858,735 +1,858,735 $9,554
     VTGN1,858,735+1,858,735$9,554
TERNS PHARMACEUTICALS INC 1,309,975 +664,076 $8,502
     TERN1,309,975+664,076$8,502
INTRA CELLULAR THERAPIES INC 110,607 -114,393 $7,922
     ITCI110,607-114,393$7,922
SAREPTA THERAPEUTICS INC 80,000 +9,800 $7,714
     SRPT80,000-85,200$7,714
INSMED INC 225,912 -168,960 $7,001
     INSM225,912-168,960$7,001
PUMA BIOTECHNOLOGY INC 1,093,273 +1,093,273 $4,734
     PBYI1,093,273+1,093,273$4,734
OCULAR THERAPEUTIX INC 700,000 +700,000 $3,122
     OCUL700,000+700,000$3,122
ARCELLX INC 48,264 -239,236 $2,679
     ACLX48,264-239,236$2,679
SPYRE THERAPEUTICS INC 125,000 +125,000 $1,501
     AGLE125,000+125,000$1,501
MERUS N V 20,000 +20,000 $550
     MRUS20,000+20,000$550
AXSOME THERAPEUTICS INC 4,963 +4,963 $395
     AXSM4,963+4,963$395

See Full List: All Stocks Held By Great Point Partners LLC
— Including:
     • Biggest new positions
     • Biggest exits
     • Biggest increased positions
     • Biggest decreased positions

See Details: Top 10 Stocks Held By Great Point Partners LLC

Great Point Partners LLC Top Holdings 13F Filings | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.